Precision radiotherapy for elderly patients with advanced solid tumors
Part of Cancer clinical trials.
This trial tests a precise type of radiation therapy (PRaG) for people aged 75 and older whose cancer has spread or cannot be treated with standard options. The goal is to see if this treatment can help control the tumor and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 75 or older
- Cancer is advanced or has spread and standard treatments have stopped working or are not possible
- Able to care for yourself or need some help (ECOG score 0-3)
- Expected to live at least 3 more months
- Kidney and liver function within safe limits as shown on blood tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining a PD-1 inhibitor (a type of immunotherapy) with radiation therapy can help older adults (70+) with esophageal squamous cell cancer who cannot have surgery. The goal is to see if this treatment is safe and effective for those with limited options.
This trial tests a special type of radiation that delivers a higher dose to the center of the tumor while limiting radiation to nearby healthy organs. It's for people with certain solid tumors that haven't spread widely or have only a few metastases.
This trial tests a new way to combine two types of radiation therapy (called PRaG-1 and PRaG) for people with advanced solid tumors that have few treatment options. The goal is to see if this approach can help your immune system fight the cancer better.
This trial tests a new way of giving radiation and first-line drugs together for elderly or frail patients with metastatic colorectal cancer. It aims to find a gentler treatment that might work well with fewer side effects.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
This trial tests a combination of two types of radiation therapy (external beam and high-dose-rate brachytherapy) for elderly or frail patients with rectal cancer who cannot or choose not to have surgery. The goal is to see if this approach is effective and well-tolerated.
Hear when a new Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.